Techyon Biotech

Pharmaceutical marketing and innovation in medicines are conducted by Techyon Biotech in India.

About Techyon Biotech

The company has 38 employees. Techyon Biotech offers products and services including ONZOLID and Combine-C2.

  • Employees 38
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Legal Name Techyon Biotech Private Limited
  • Date of Incorporation 15 Dec, 2004
  • Jurisdiction Kanpur, Uttar Pradesh, India
Key Metrics
  • Annual Revenue
    ₹6.76 Cr

    FY 2024 · +3% YoY

  • Net Profit
    ₹0.07 Cr

    FY 2024 · 1% margin

  • EBITDA
    ₹0.74 Cr

    FY 2024 · 11% margin

  • Employee Count
    38

Products & Services of Techyon Biotech

Techyon Biotech offers a comprehensive portfolio of products and services, including ONZOLID and Combine-C2.

ONZOLID
Pharmaceuticals

ONZOLID is utilized as a medication for combating severe bacterial infections, where effective treatment approaches are applied for patient recovery.

Combine-C2
Pharmaceuticals

Combine-C2 is employed for addressing osteoarthritis, with an emphasis on affordability to ensure accessible treatment options are provided.

Board of directors of Techyon Biotech Private Limited (Techyon Biotech)

Techyon Biotech Private Limited is the primary company behind Techyon Biotech. The board of Techyon Biotech Private Limited currently have 2 directors; the longest-serving is Rajesh Sharma, appointed in 2004. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Rajesh Sharma
DIN 00258512
Director15 Dec 200421 yrs 9 moTechyon Biotech Private Limited
Sarika Sharma
DIN 00250380
Director15 Dec 200421 yrs 9 moTechyon Biotech Private Limited

Financials of Techyon Biotech

Figures of Techyon Biotech Private Limited, the primary company behind Techyon Biotech, for FY 2024. Revenue was ₹6.76 Cr (+3% year on year). Net profit was ₹0.07 Cr (1% margin). EBITDA was ₹0.74 Cr (11% margin). Revenue has grown at a compounded annual rate of +11% over three years and +5% over five years.

  • ₹6.76 CrRevenue · FY 2024 · +3% YoY
  • ₹0.07 CrNet profit · 1% margin
  • ₹0.74 CrEBITDA · 11% margin
  • ₹0.05 CrPaid-up capital
  • 38Employees (provident fund records)
  • +11%Revenue CAGR, 3 years
  • +5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Techyon Biotech Private Limited are on its company page.

Premium access

Detailed financial statements for Techyon Biotech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Techyon Biotech

10 companies that operate in the same segment as Techyon Biotech (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Genetic services are provided by Colossal's laboratory operations.
2021Austin, Texas, United StatesUSD 617.6 M––
Research lab engaged in pharmacological measurements on therapeutic protein variants
2018United StatesUSD 78.19 M–22
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, India–USD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, India–USD 4.22 M228
Medical research labs are provided by GALY for scientific purposes.
2018Boston, Massachusetts, United StatesUSD 61.59 M–25
Laboratory focused on biotechnology & molecule research services
2018Cambridge, Massachusetts, United StatesUSD 32.68 M––
Laboratory delivers discovery & research in nuclear and particle physics
1947United States––2,436
Research and manufacturing of hemp products are conducted by BRC.
2017Monterey, California, United StatesUSD 25.26 M–16
Genome sequencing studies are conducted for medical research purposes.
2020Cambridge, Cambridgeshire, United KingdomUSD 11.26 M–12
Novel immunotherapy therapeutic targets are discovered through laboratory research.
2019Branford, Connecticut, United StatesUSD 92 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Techyon Biotech

Techyon Biotech has 38 employees.

The primary company behind Techyon Biotech, Techyon Biotech Private Limited, reported revenue of β‚Ή6.76 Cr for FY 2024, up 3% year on year.

Techyon Biotech is identified as a leading pharmaceutical company in India, where partnerships with entities like Akums Drugs and Pharmaceuticals Ltd are formed for manufacturing. A commitment to quality excellence and healthcare innovation is maintained, with divisions such as Chrono-Cure dedicated to chronic disease treatments. The company is steered by principles of accessibility and affordability, fostering collaborations with healthcare professionals, as guided by its directors. Mutual trust with thousands of doctors is built through a focus on satisfaction for both professionals and patients, advancing global healthcare standards.

Techyon Biotech offers ONZOLID and Combine-C2.

Techyon Biotech operates through Techyon Biotech Private Limited.

The legal entities of Techyon Biotech currently have 2 directors, including Rajesh Sharma, Sarika Sharma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available